Engineered biocatalysts and methods for synthesizing chiral amines
申请人:Codexis, Inc.
公开号:US10435674B2
公开(公告)日:2019-10-08
The present disclosure provides engineered transaminase polypeptides for the production of amines, polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to prepare compounds useful in the production of active pharmaceutical agents.
Design of novel synthetic MTS conjugates of bile acids for site-directed sulfhydryl labeling of cysteine residues in bile acid binding and transporting proteins
作者:Abhijit Ray、Antara Banerjee、Cheng Chang、Chandra M. Khantwal、Peter W. Swaan
DOI:10.1016/j.bmcl.2005.12.050
日期:2006.3
The purpose of this study was to design bile acid-containing methanethiosulfonate (MTS) agents with appropriate physical attributes to effectively modify the cysteine residues present in the human apical sodium-dependent bile acid transporter. Four physical properties including surface area, molecular volume, Clog P, and dipole moment were calculated for each semiempirically optimized structure of NITS compounds. The specificity of the synthesized bile acid-MTS conjugate toward native cysteines and putative bile acid interacting domains of hASBT was supported by the effect of 1 mM cholyl-MTS, cholylglycyl-MTS, and 3-amino-cholyl-MTS on uptake activity, that displayed a significant decrease in TCA affinity (K-T = 69.9 +/- 4.5, 69.01 +/- 6.2, and 63.24 +/- 0.26 mu M and J(max) = 35.8 +/- 0.3, 24.03 +/- 1.22, 46.49 +/- 5.01 pmol mg protein min(-1), respectively). These compounds prove to be effective tools in probing the structural and functional effects of cysteine residues in bile acid binding and transporting proteins. (C) 2005 Elsevier Ltd. All rights reserved.
Jones; Webb; Smith, Journal of the Chemical Society, 1949, p. 2146,2167
作者:Jones、Webb、Smith
DOI:——
日期:——
ENGINEERED BIOCATALYSTS AND METHODS FOR SYNTHESIZING CHIRAL AMINES
申请人:CODEXIS, INC.
公开号:US20150329837A1
公开(公告)日:2015-11-19
The present disclosure provides engineered transaminase polypeptides for the production of amines, polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to prepare compounds useful in the production of active pharmaceutical agents.